Prognostic factors associated with survival in patients with pancreatic cancer treated on early phase immune-checkpoint inhibitor clinical trials

被引：0
|
作者：
Surana, Rishi
Rogers, Jane E.
Nogueras-Gonzalez, Graciela M.
Hong, David S.
Yap, Timothy A.
Ahnert, Jordi Rodon
Naing, Aung
Wolff, Robert A.
Smaglo, Brandon George
Meric-Bernstam, Funda
Subbiah, Vivek
Pant, Shubham
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Clin Pharm Programs, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Div Canc Med, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
577
引用
收藏
页数：3
相关论文
共 50 条
  • [41] The safety and efficacy of immune-checkpoint inhibitor therapy in HIV infected cancer patients.
    Myint, Phyo Thazin
    Ali, Faisal S.
    Verghese, Dhiran
    Alrifai, Taha
    Thet, Aye Mon
    Kozma, Kelley Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Development of a novel prognostic scoring system for patient selection in immune checkpoint inhibitor phase 1 clinical trials
    Sen, Shiraj
    Hess, Kenneth
    Hong, David
    Naing, Aung
    Piha-Paul, Sarina
    Janku, Filip
    Fu, Siqing
    Liu, Holly
    Jiang, Yunfang
    Khanji, Rahil
    Karp, Daniel
    Tsimberidou, Apostolia
    Tannir, Nizar
    Meric-Bernstam, Funda
    Subbiah, Vivek
    CANCER RESEARCH, 2017, 77
  • [43] Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
    Tison, Alice
    Garaud, Soizic
    Chiche, Laurent
    Cornec, Divi
    Kostine, Marie
    NATURE REVIEWS RHEUMATOLOGY, 2022, 18 (11) : 641 - 656
  • [44] THE RISK OF DIARRHEA AND COLITIS IN PATIENTS WITH LUNG CANCER UNDERGOING IMMUNE-CHECKPOINT INHIBITOR THERAPY
    Bishay, Kirles
    Tandon, Parul
    Bourassa-Blanchette, Samuel
    Parlow, Simon
    Laurie, Scott
    McCurdy, Jeffrey D.
    GASTROENTEROLOGY, 2018, 154 (06) : S104 - S105
  • [45] Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
    Tison, Alice
    Garaud, Soizic
    Chiche, Laurent
    Cornec, Divi
    Kostine, Marie
    NATURE REVIEWS RHEUMATOLOGY, 2022,
  • [46] Reported Cardiovascular Events in Lung Cancer Patients after Immune-Checkpoint Inhibitor Therapy
    Yeung, S. -C.
    Qdaisat, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S78 - S78
  • [47] Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
    Alice Tison
    Soizic Garaud
    Laurent Chiche
    Divi Cornec
    Marie Kostine
    Nature Reviews Rheumatology, 2022, 18 : 641 - 656
  • [48] Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study
    Bersanelli, Melissa
    Lattanzi, Elisabetta
    D'Abbiero, Nunziata
    Buti, Sebastiano
    Leonetti, Alessandro
    Cane, Maria Giulia
    Trapani, Salvatore
    Gravina, Giovanni Luca
    Porzio, Giampiero
    Cannita, Katia
    Di Marino, Pietro
    Grassadonia, Antonino
    Tinari, Nicola
    De Tursi, Michele
    Giaiacopi, Elisa
    Michiara, Maria
    Bordi, Paola
    Perrone, Fabiana
    Caravatta, Luciana
    Trignani, Marianna
    Genovesi, Domenico
    Natoli, Clara
    Ficorella, Corrado
    Tiseo, Marcello
    Cortellini, Alessio
    BIOMEDICAL REPORTS, 2020, 12 (02) : 59 - 67
  • [49] Prognostic factors for survival in early-phase trials in hematology
    Jamal, R.
    Hristova, G.
    Holcroft, C.
    Assouline, S. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell Lung Cancer
    Gao, Chanchan
    Gu, Xuyu
    Chen, Yan
    Zhou, Min
    Jiang, Feng
    Zheng, Shiya
    MEDICAL SCIENCE MONITOR, 2021, 27
12345